Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Third Rock Ventures
Biotech
Third Rock-backed Merida unveils with $121M for autoimmune plans
Third Rock has unveiled Merida and its $121 million series A that the firm co-led with Bain Capital Life Sciences and BVF Partners.
James Waldron
Apr 8, 2025 11:03am
Marea, Ashibio, Arvinas & more—Chutes & Ladders
Jun 21, 2024 8:30am
Marea ropes in $190M for clinical-stage cardiometabolic program
Jun 18, 2024 7:00am
Rapport upsizes IPO, tacking on $32M
Jun 7, 2024 11:00am
Third Rock, J&J neuroscience spinout Rapport outlines IPO plans
May 20, 2024 5:13am
Third Rock, Novo Holdings-backed Clasp hooks $150M series A
Mar 20, 2024 7:00am
